Nicosia Matthew 4
4 · CANNAPHARMARX, INC. · Filed Jun 19, 2020
Insider Transaction Report
Form 4
Nicosia Matthew
Director10% Owner
Transactions
- Other
Series A Preferred
2018-04-20$1.00/sh−10,000$10,000→ 26,000 totalExercise: $0.00From: 2018-06-17→ Common Stock (12,500,000 underlying) - Sale
Series A Preferred
2019-06-17$1.00/sh−4,000$4,000→ 16,000 totalExercise: $0.00From: 2018-04-20→ Common Stock (5,000,000 underlying)
Footnotes (2)
- [F1]The conversion rights of the Series A Convertible Preferred Stock do not expire and can be exercised at any time.
- [F2]The Reporting Person subscribed and paid for 30,000 Series A Convertible Preferred Shares directly from the Issuer. Subsequently, he verbally agreed to sell 10,000 of these shares, but the buyer failed to pay for the shares and the agreement was terminated.